Department of Psychiatry and Pharmacology, Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston Salem, North Carolina.
Alcohol Clin Exp Res. 2018 Jan;42(1):12-20. doi: 10.1111/acer.13545. Epub 2017 Dec 5.
Neuroactive steroids such as (3α,5α)3-hydroxypregnan-20-one (3α,5α-THP, allopregnanolone) are potent neuromodulators that enhance GABAergic neurotransmission and produce inhibitory neurobehavioral and anti-inflammatory effects. Chronic ethanol (EtOH) consumption reduces 3α,5α-THP levels in human plasma, but has brain region- and species-specific effects on central nervous system levels of 3α,5α-THP. We explored the relationship between 3α,5α-THP levels in the hippocampus and voluntary EtOH consumption in the cynomolgus monkey following daily self-administration of EtOH for 12 months and further examined the relationship with hypothalamic-pituitary-adrenal (HPA) axis function prior to EtOH exposure. We simultaneously explored hippocampus levels of monocyte chemoattractant protein 1 (MCP-1), a pro-inflammatory cytokine that plays an important role in the neuroimmune response to EtOH, following chronic self-administration.
Monkeys were subjected to scheduled induction of water and EtOH consumption (0 to 1.5 g/kg) over 4 months, followed by free access to EtOH or water for 22 h/d over 12 months. Immunohistochemistry was performed using an anti-3α,5α-THP or anti-MCP-1 antibody. Prolonged voluntary drinking resulted in individual differences in EtOH consumption that ranged from 1.2 to 4.2 g/kg/d over 12 months.
Prolonged EtOH consumption increased cellular 3α,5α-THP immunoreactivity by 12 ± 2% (p < 0.05) and reduced MCP-1 immunoreactivity by 23 ± 9% (p < 0.05) in the hippocampus CA1. In both cases, the effect of EtOH was most pronounced in heavy drinkers that consumed ≥3 g/kg for ≥20% of days. 3α,5α-THP immunoreactivity was positively correlated with average daily EtOH intake (Spearman r = 0.76, p < 0.05) and dexamethasone inhibition of HPA axis function (Spearman r = 0.9, p < 0.05). In contrast, MCP-1 immunoreactivity was negatively correlated with average daily EtOH intake (Spearman r = -0.78, p < 0.05) and dexamethasone suppression of HPA axis function (Spearman r = -0.76, p < 0.05). Finally, 3α,5α-THP and MCP-1 immunoreactivity were inversely correlated with each other (Spearman r = -0.68, p < 0.05).
These data indicate that voluntary, long-term EtOH consumption results in higher levels of 3α,5α-THP, while decreasing levels of MCP-1 in the CA1 hippocampus, and that both changes may be linked to HPA axis function and the magnitude of voluntary EtOH consumption.
神经活性甾体,如(3α,5α)3-羟孕烷-20-酮(3α,5α-THP,别孕烯醇酮)是增强 GABA 能神经传递的强效神经调节剂,可产生抑制性神经行为和抗炎作用。慢性乙醇(EtOH)消耗会降低人血浆中的 3α,5α-THP 水平,但对中枢神经系统中的 3α,5α-THP 水平具有脑区和物种特异性影响。我们在恒河猴中探索了海马体中 3α,5α-THP 水平与自愿性 EtOH 消耗之间的关系,在经过 12 个月的每日自我给予 EtOH 后,我们进一步研究了其与下丘脑-垂体-肾上腺(HPA)轴功能之间的关系,然后再进行 EtOH 暴露。我们同时探索了海马体中单核细胞趋化蛋白 1(MCP-1)的水平,MCP-1 是一种促炎细胞因子,在对 EtOH 的神经免疫反应中起着重要作用。
猴子经历了为期 4 个月的水和 EtOH 摄入的计划诱导(0 至 1.5g/kg),然后进行了为期 12 个月的每日 22 小时自由摄取 EtOH 或水。使用抗 3α,5α-THP 或抗 MCP-1 抗体进行免疫组织化学。长期自愿饮酒导致 EtOH 消耗的个体差异,在 12 个月期间,每日消耗范围为 1.2 至 4.2g/kg。
长期 EtOH 消耗使海马体 CA1 区的细胞 3α,5α-THP 免疫反应性增加了 12±2%(p<0.05),并使 MCP-1 免疫反应性降低了 23±9%(p<0.05)。在这两种情况下,EtOH 的作用在每日至少消耗≥3g/kg 且≥20%天数的重度饮酒者中最为明显。3α,5α-THP 免疫反应性与平均每日 EtOH 摄入量呈正相关(Spearman r=0.76,p<0.05),与 HPA 轴功能的地塞米松抑制呈正相关(Spearman r=0.9,p<0.05)。相比之下,MCP-1 免疫反应性与平均每日 EtOH 摄入量呈负相关(Spearman r=-0.78,p<0.05),与 HPA 轴功能的地塞米松抑制呈负相关(Spearman r=-0.76,p<0.05)。最后,3α,5α-THP 和 MCP-1 免疫反应性呈负相关(Spearman r=-0.68,p<0.05)。
这些数据表明,自愿性长期 EtOH 消耗导致海马体 CA1 区中 3α,5α-THP 水平升高,同时 MCP-1 水平降低,这两种变化可能与 HPA 轴功能和自愿性 EtOH 消耗的程度有关。